In response to the RFA-RM-05-014, we plan to use both solid- and solution-phase strategies to synthesize several pilot-scale libraries to be submitted to NIH for subsequent distribution for various biological assays.
Our aim i s to prepare chemically pure, structurally diverse small-molecule compounds. These small-molecule compounds will be prepared by adaptation of published synthetic routes or, as appropriate, by development of novel synthetic strategies. Diversity-oriented synthesis (DOS) libraries will generally have ~100-200 members each with =90% purity of non-commercial small-molecules. Our plan is to prepare two types of libraries for each scaffold: (i) a small demo library to test the chemistry and validate the procedures, using the IRORI system for compound synthesis and tracking; (ii) a Trident- or IRORI-based library to deliver a focused library of compounds. The output of libraries (i) and (ii) will be combined, archived, and made available for biochemical evaluation. The dinitrodifluorobenzene-based scaffold will be prepared in larger number and quantity. Some of the solid-phase synthesis libraries will be generated with a built-in hydrophilic handle with site-specific functional groups so that these compounds can be subsequently tagged for specific assays while others will be prepared without any handle. Each compound will be analyzed by HPLC for purity and its identity confirmed by mass spectroscopy. If needed, FlashTube advanced flash chromatography will be used for compound purification. The NIH PubChem will be used for management of our various pilot libraries and we plan to set up a UC Davis Combinatorial Chemistry web site with links to PubChem. As required by the RFA, at least 10 mg of each library member will be archived and each will have =90% purity. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Biotechnology Resource Grants (P41)
Project #
5P41GM076151-02
Application #
7125571
Study Section
Special Emphasis Panel (ZGM1-PPBC-7 (PL))
Program Officer
Schwab, John M
Project Start
2005-09-23
Project End
2008-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
2
Fiscal Year
2006
Total Cost
$453,296
Indirect Cost
Name
University of California Davis
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Coffman, Keith C; Nguyen, Huy H; Phuan, Puay-Wah et al. (2014) Constrained bithiazoles: small molecule correctors of defective ?F508-CFTR protein trafficking. J Med Chem 57:6729-38
MacDonald, Jacob P; Shupe, Benjamin H; Schreiber, John D et al. (2014) Counterion effects in the catalytic stereoselective synthesis of 2,3'-pyrrolidinyl spirooxindoles. Chem Commun (Camb) 50:5242-4
Mills, Aaron D; Yoo, Choong; Butler, Jeffrey D et al. (2010) Design and synthesis of a hybrid potentiator-corrector agonist of the cystic fibrosis mutant protein DeltaF508-CFTR. Bioorg Med Chem Lett 20:87-91
Carpenter, Richard D; Natarajan, Arutselvan; Lau, Edmond Y et al. (2010) Halogenated benzimidazole carboxamides target integrin alpha4beta1 on T-cell and B-cell lymphomas. Cancer Res 70:5448-56
Ye, Long; Knapp, John M; Sangwung, Panjamaporn et al. (2010) Pyrazolylthiazole as DeltaF508-cystic fibrosis transmembrane conductance regulator correctors with improved hydrophilicity compared to bithiazoles. J Med Chem 53:3772-81
Meng, Liping; Lorsbach, Beth A; Sparks, Thomas C et al. (2010) Parallel Synthesis of bis-heterocyclic isoxazolylmethyl- and isoxazolinylmethylpyrazoles. J Comb Chem 12:129-36
Yu, Gui J; Iwamoto, Satori; Robins, Lori I et al. (2009) 3-(Arylthiomethyl)isoxazole-4,5-dicarboxamides: chemoselective nucleophilic chemistry and insecticidal activity. J Agric Food Chem 57:7422-6
Kappel, Joseph C; Fan, Yi C; Lam, Kit S (2009) Application of the ""libraries from libraries"" concept to ""one-bead one-compound"" combinatorial chemistry. Adv Exp Med Biol 611:21-2
Milinkevich, Kristin A; Yoo, Choong L; Sparks, Thomas C et al. (2009) Synthesis and biological activity of 2-(4,5-dihydroisoxazol-5-yl)-1,3,4-oxadiazoles. Bioorg Med Chem Lett 19:5796-8
Carpenter, Richard D; Andrei, Mirela; Aina, Olulanu H et al. (2009) Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin. J Med Chem 52:14-9

Showing the most recent 10 out of 24 publications